Literature DB >> 21035908

Papillary squamous cell carcinoma of the head and neck: a clinicopathologic series.

Jonathon O Russell1, Aaron P Hoschar, Joseph Scharpf.   

Abstract

PURPOSE: Papillary squamous cell carcinoma (PSCC) is a rare malignancy that has been associated with human papillomavirus. We present all cases of this disease at a single academic teaching hospital over the last 30 years.
MATERIALS AND METHODS: A retrospective chart review was performed for all patients with a diagnosis of PSCC. Of 65 patients identified, 52 were included after meeting established diagnostic criteria. Chart reviews were performed for patient demographics, overall survival, and disease-free survival.
RESULTS: Mean age at diagnosis was 65 years, with a male to female ratio of 2.3:1. The majority of lesions (n = 34, 65.4%) arose in areas commonly affected by benign squamous papillomas, with the laryngopharynx the most commonly affected (n = 19, 36.5%), followed by the oral cavity (n = 18, 34.6%), sinonasal tract (n = 8, 15.4%), and oropharynx (n = 7, 13.5%). Two- and 5-year disease-free survival rate was 68% and 46%, respectively. Overall survival rate was 90% and 72% at 2 and 5 years, respectively.
CONCLUSIONS: Papillary squamous cell carcinoma of the head and neck is a distinct variant of conventional squamous cell carcinoma with a good prognosis despite high locoregional recurrence rates. Histology and subsite localization corroborate existing evidence that human papillomavirus may be involved.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21035908     DOI: 10.1016/j.amjoto.2010.09.010

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  9 in total

Review 1.  Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants.

Authors:  Bruce M Wenig
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 2.  How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?

Authors:  Fernando López; Michelle D Williams; Antonio Cardesa; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Iain J Nixon; Juan P Rodrigo; Nabil F Saba; William M Mendenhall; Miquel Quer; Carlos Suárez; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-31       Impact factor: 2.503

3.  CD44 expression in intraoral salivary ductal papillomas and oral papillary squamous cell carcinoma.

Authors:  Sarah G Fitzpatrick; Lindsay J Montague; Donald M Cohen; Indraneel Bhattacharyya
Journal:  Head Neck Pathol       Date:  2012-11-13

4.  Papillary squamous cell carcinoma of the mandibular gingiva.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

5.  Papillary squamous cell carcinoma of the oral cavity with acantholytic and pseudovascular features.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2011-11-03

6.  Papillary variant of squamous cell carcinoma arising on the gingiva: 61 cases reported from within a larger series of gingival squamous cell carcinoma.

Authors:  Sarah G Fitzpatrick; Ashley N Neuman; Donald M Cohen; Indraneel Bhattacharyya
Journal:  Head Neck Pathol       Date:  2013-04-26

7.  Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus.

Authors:  Mitra Mehrad; Danielle H Carpenter; Rebecca D Chernock; Hongwei Wang; Xiao-Jun Ma; Yuling Luo; Jingqin Luo; James S Lewis; Samir K El-Mofty
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

8.  Palate Squamous Cell Carcinomas:A Ten-Year Single Institute Experience.

Authors:  Adrian PĂtru; Valeriu Şurlin; Claudiu MĂrgĂritescu; Eduard CiucĂ; Otilia Clara MĂrgĂritescu; Adrian Camen
Journal:  Curr Health Sci J       Date:  2020-12-31

9.  Middle ear squamous papilloma: A report of four cases analyzed by HPV and EBV in situ hybridization.

Authors:  Han Zhou; Zhibin Chen; Weiming Zhang; Guangqian Xing
Journal:  Oncol Lett       Date:  2013-11-11       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.